Beijing Strong Biotechnologies Inc (SHE:300406) — Market Cap & Net Worth
Market Cap & Net Worth: Beijing Strong Biotechnologies Inc (300406)
Beijing Strong Biotechnologies Inc (SHE:300406) has a market capitalization of $995.23 Million (CN¥6.80 Billion) as of June 17, 2026. Listed on the SHE stock exchange, this China-based company holds position #9114 globally and #2329 in its home market, demonstrating a -0.43% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Beijing Strong Biotechnologies Inc's stock price CN¥11.60 by its total outstanding shares 586308628 (586.31 Million). Review 300406 total debt and obligations to assess the company's total debt and financial obligations.
Beijing Strong Biotechnologies Inc Market Cap History: 2015 to 2026
Beijing Strong Biotechnologies Inc's market capitalization history from 2015 to 2026. Data shows change from $1.86 Billion to $995.23 Million (-3.81% CAGR).
Beijing Strong Biotechnologies Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Beijing Strong Biotechnologies Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.69x
Beijing Strong Biotechnologies Inc's market cap is 0.69 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.15x
Beijing Strong Biotechnologies Inc's market cap is 2.15 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.86 Billion | $566.20 Million | $245.04 Million | 3.29x | 7.61x |
| 2016 | $1.76 Billion | $667.40 Million | $271.65 Million | 2.64x | 6.48x |
| 2017 | $1.22 Billion | $694.28 Million | $273.15 Million | 1.76x | 4.48x |
| 2018 | $807.68 Million | $774.18 Million | $300.67 Million | 1.04x | 2.69x |
| 2019 | $1.35 Billion | $840.86 Million | $331.65 Million | 1.60x | 4.07x |
| 2020 | $2.09 Billion | $848.12 Million | $112.28 Million | 2.47x | 18.62x |
| 2021 | $1.66 Billion | $1.60 Billion | $405.65 Million | 1.04x | 4.10x |
| 2022 | $1.38 Billion | $1.51 Billion | $389.10 Million | 0.92x | 3.56x |
| 2023 | $1.62 Billion | $1.74 Billion | $523.74 Million | 0.93x | 3.10x |
| 2024 | $1.15 Billion | $1.66 Billion | $532.64 Million | 0.69x | 2.15x |
Competitor Companies of 300406 by Market Capitalization
Companies near Beijing Strong Biotechnologies Inc in the global market cap rankings as of June 17, 2026.
Key companies related to Beijing Strong Biotechnologies Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #127 globally with a market cap of $177.57 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #182 globally with a market cap of $128.10 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #626 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #663 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #127 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.57 Billion | $472.63 |
| #182 | Danaher Corporation | NYSE:DHR | $128.10 Billion | $181.35 |
| #626 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $573.00 |
| #663 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Beijing Strong Biotechnologies Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Beijing Strong Biotechnologies Inc's market cap moved from $1.86 Billion to $ 995.23 Million, with a yearly change of -3.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥995.23 Million | -11.25% |
| 2025 | CN¥1.12 Billion | -2.17% |
| 2024 | CN¥1.15 Billion | -29.30% |
| 2023 | CN¥1.62 Billion | +17.19% |
| 2022 | CN¥1.38 Billion | -16.90% |
| 2021 | CN¥1.66 Billion | -20.38% |
| 2020 | CN¥2.09 Billion | +55.09% |
| 2019 | CN¥1.35 Billion | +66.93% |
| 2018 | CN¥807.68 Million | -33.93% |
| 2017 | CN¥1.22 Billion | -30.58% |
| 2016 | CN¥1.76 Billion | -5.52% |
| 2015 | CN¥1.86 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Beijing Strong Biotechnologies Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $995.23 Million USD |
| MoneyControl | $995.23 Million USD |
| MarketWatch | $995.23 Million USD |
| marketcap.company | $995.23 Million USD |
| Reuters | $995.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Beijing Strong Biotechnologies Inc
Beijing Strong Biotechnologies,Inc. researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally. The company offers biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activ… Read more